Clinical and molecular characteristics of the 44 patients with CML
| Characteristics . | Value . |
|---|---|
| Sex, n (%) | |
| Male | 34 (77) |
| Female | 10 (23) |
| Age group, y, n (%) | |
| < 35 | 9 (21) |
| 35-60 | 27 (61) |
| > 60 | 8 (18) |
| Age, y | |
| Median | 47 |
| Range | 17-78 |
| Bone marrow blasts count, % | |
| Median | 3.6 |
| Range | 0.5-96 |
| Disease status, n (%) | |
| Chronic phase | 14 (32) |
| Accelerated phase | 4 (9) |
| Blastic crisis | 26 (59) |
| Characteristics . | Value . |
|---|---|
| Sex, n (%) | |
| Male | 34 (77) |
| Female | 10 (23) |
| Age group, y, n (%) | |
| < 35 | 9 (21) |
| 35-60 | 27 (61) |
| > 60 | 8 (18) |
| Age, y | |
| Median | 47 |
| Range | 17-78 |
| Bone marrow blasts count, % | |
| Median | 3.6 |
| Range | 0.5-96 |
| Disease status, n (%) | |
| Chronic phase | 14 (32) |
| Accelerated phase | 4 (9) |
| Blastic crisis | 26 (59) |
Patients with 3q26 abnormalities are not included in this study.